112019 ⎘
Bacteriophages; Details dsDNA Bacteriophages; Podoviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
BACTERIOPHAGE, BACTERIAL WILT DISEASE CONTROL AGENT, AND BACTERIAL WILT DISEASE CONTROL METHOD
#2PHAGE ENGINEERING: PROTECTION BY CIRCULARIZED INTERMEDIATE
#3Methods and Systems for the Rapid Detection of Listeria Using Infectious Agents
#4Oncolytic T7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating melanoma
#5Methods and devices related to controlled delivery of phages as a theranostic tool
#6Methods and systems for rapid detection of microorganisms using infectious agents
#7Composition of matter: engineering of phage K1E
#8Phage engineering: protection by circularized intermediate
#9Bacteriophage recombination followed by blockage of non-recombinant bacteriophage replication
#10Recombinant K1-5 bacteriophages and uses thereof
#11Bacteria identification and antibiotic susceptibility profiling device
#12Bacteriophage engineering methods
#13RECOMBINANT PHAGE AND METHODS
#14Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#15INHIBITION OF BIOFILM FORMATION WITH GENETICALLY ENGINEERED BACTERIOPHAGES
#16Methods and systems for rapid detection of microorganisms using infectious agents
#17Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#18Recombinant phage and methods
#19BACTERIOPHAGES EXPRESSING AMYLOID PEPTIDES AND USES THEREOF
#20PRODUCTION AND IN VIVO ASSEMBLY OF SOLUBLE RECOMBINANT ICOSAHEDRAL VIRUS-LIKE PARTICLES
#21Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2)
#22Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions